Global Prospective Case Series Using a Single-Use Duodenoscope

NACompletedINTERVENTIONAL
Enrollment

551

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

November 23, 2022

Study Completion Date

January 5, 2023

Conditions
Endoscopic Retrograde Cholangiopancreatography
Interventions
DEVICE

Exalt Model D Single-Use Duodenoscope

Subjects will have a clinically indicated per standard of care ERCP or other duodenoscope-based procedure performed with the Exalt single use duodenoscope study device.

Trial Locations (22)

10065

Cornell Medical Center, New York

11030

North Shore University Hospital, Manhasset

15213

University of Pittsburgh Medical Center, Pittsburgh

44195

Cleveland Clinic, Cleveland

46202

Indianapolis University Hospital, Indianapolis

55905

Mayo Clinic, Rochester

60637

University of Chicago, Chicago

78229

The University of Texas Health Science Center at San Antonio, San Antonio

90095

University of California Los Angeles Medical Center, Los Angeles

98101

Virginia Mason Medical Center, Seattle

700054

Apollo Multispeciality Hospitals, Kolkata

02215

Beth Israel Deaconess Medical Center, Boston

Unknown

Metro North Hospital and Health Services, Brisbane

Institut Paoli-Calmettes, Marseille

Evangelisches Krankenhaus Düsseldorf, Düsseldorf

Prince of Wales Hospital, Hong Kong

Asian Institute of Gastroenterology, Hyderabad

Humanitas University, Milan

Singapore General Hospital, Singapore

Dr. George Mukhari Academic Hospital, Ga-Rankuwa

M5B 1W8

St. Michael's Hospital - Unity Health, Toronto

3015 CN

Erasmus University Medical Center of Rotterdam, Rotterdam

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT04103749 - Global Prospective Case Series Using a Single-Use Duodenoscope | Biotech Hunter | Biotech Hunter